Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis

Published:2022-01 Issue:1 Volume:25 Page:133-146
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Keeney Edna,Thom Howard,Turner Emma,Martin Richard M.,Morley Josie,Sanghera Sabina

Funder

National Institute for Health Research

Cancer Research UK

University Hospitals Bristol NHS Foundation Trust

University of Bristol

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference84 articles.

1. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study;Rosario;BMJ,2012

2. Serial biopsy results in prostate cancer screening study;Roehl;J Urol,2002

3. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study;Ahmed;Lancet,2017

4. Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial;Martin;JAMA,2018

5. Quality-of-life effects of prostate-specific antigen screening;Heijnsdijk;N Engl J Med,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cost-Effectiveness of Germline BReast CAncer Gene Testing in Metastatic Prostate Cancer Followed by Cascade Testing of First-Degree Relatives of Mutation Carriers;Value in Health;2024-07

2. Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate Cancer in the United States;PharmacoEconomics;2023-11-07

3. Economic evaluation of prostate cancer risk assessment methods: A cost‐effectiveness analysis using population data;Cancer Medicine;2023-09-23

4. Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP);BMC Health Services Research;2023-06-09

5. Kosteneffektivität der Diagnostik von Prostatakrebs: Untersuchung neuer Innovationen;TumorDiagnostik & Therapie;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3